Angiogenesis in bladder cancer--prognostic marker and target for future therapy. (Q34657987)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Angiogenesis in bladder cancer--prognostic marker and target for future therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Edward H Streeter

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

85-100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

A novel mechanism of capillary growth in the rat pulmonary microcirculation

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Isolation of putative progenitor endothelial cells for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Origins of circulating endothelial cells and endothelial outgrowth from blood

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Vasculogenic mimicry and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Organ targeting in vivo using phage display peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Detection of Angiogenesis Activity in Malignant Bladder Tissue and Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Determination of cytosolic citrulline and nitrate as indicators of nitric oxide in bladder cancer: possible association with basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

c-myc in bladder cancer. Clinical findings and analysis of mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Recovery of epidermal growth factor in voided urine of patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Expression of scatter factor in human bladder carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS CORRELATION WITH BLADDER CANCER RECURRENCE RATES

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Thymidine phosphorylase is angiogenic and promotes tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Association of ovarian Malignancy With Expression of Paltelet-Derived Endothelial Cell Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Expression of platelet-derived endothelial cell growth factor in bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Original Articles: Bladder Cancer: Long-Term Outcome Related to Epidermal Growth Factor Receptor Status in Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Effects of epidermal growth factor on the invasion activity of the bladder cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Serum levels of a tissue inhibitor of metalloproteinases-1 (TIMP-1) in bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Anti-angiogenic agents: clinical trial design and therapies in development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Suramin, an active drug for prostate cancer: interim observations in a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Antitumour effects of the angiogenesis inhibitor AGM-1470 on rat urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl) nitrosamine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Microvessel density as a prognostic marker for transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Expression of cyclooxygenase-2 in patients with bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900013-0

7 January 2021

10.1016/S0960-7404(02)00013-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031871%20AND%20SRC:MED&resulttype=core&format=json

release_kvliqz6ghzfurloyetsudk4wey

9 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kvliqz6ghzfurloyetsudk4wey

24 November 2022

mapped directly with Wikidata item

1 reference